(2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6.
(2022). Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. Bmj Open, 12, e055015. http://doi.org/10.1136/bmjopen-2021-055015.
(2022). Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia, 65, 644-656. http://doi.org/10.1007/s00125-021-05640-y.
(2022). Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. Plos Med, 19, e1003870. http://doi.org/10.1371/journal.pmed.1003870.